TLPH
TALPHERA, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.08
+0.00%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.06
- EPS estimate
- -$0.06
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +5.0%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.06 | -$0.06 | Beat 4.00% | — |
| May 13, 2026 | -$0.07 | -$0.04 | Beat 42.86% | — |
| Mar 23, 2026 | -$0.07 | -$0.06 | Beat 20.00% | — |
| Nov 12, 2025 | -$0.07 | -$0.11 | Miss -46.67% | $1.0K |
| Aug 14, 2025 | -$0.12 | -$0.10 | Beat 16.67% | — |
| Mar 31, 2025 | -$0.21 | -$0.07 | Beat 66.67% | — |
| Aug 14, 2024 | -$0.22 | -$0.15 | Beat 31.82% | — |
| Dec 6, 2023 | -$0.28 | -$0.08 | Beat 71.43% | $281.0K |
| Aug 10, 2023 | -$0.53 | -$0.41 | Beat 22.64% | $253.0K |
| Mar 30, 2019 | — | -$3.47 | — | $265.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026